Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients

被引:28
|
作者
Rocio, Carolina [1 ]
Amato, Valdir Sabbaga [1 ]
Camargo, Raphael A. [1 ]
Tuon, Felipe F. [2 ]
Nicodemo, Antonio Carlos [1 ]
机构
[1] Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, Sao Paulo, Brazil
[2] Univ Fed Parana, Clin Univ Hosp, Div Infect Dis, BR-80060000 Curitiba, PR, Brazil
关键词
Amphotericin B; Leishmania treatment; Leishmaniasis;
D O I
10.1093/trstmh/tru011
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Studies assessing the efficacy of liposomal amphotericin B (LAB) in the treatment of patients with mucosal leishmaniasis (ML) are very scarce in the literature and an optimal dose regimen has not yet been defined. Methods: We performed a retrospective and descriptive analysis from records of 16 patients with ML treated with LAB. The mean daily dose of LAB was 2.5 mg/kg/day. Results: Healing of the lesion was observed in 14 (88%) of the 16 patients. The mean cumulative doses, excluding the two treatment failures, were 2265 mg and 33 mg/kg. Conclusion: Liposomal amphotericin B in the cumulative dose of 30 to 35 mg/kg was able to achieve 100% effectiveness.
引用
收藏
页码:176 / 178
页数:3
相关论文
共 50 条
  • [31] Treatment of visceral leishmaniasis in HIV-infected patients:: a randomized trial comparing meglumine antimoniate with amphotericin B
    Laguna, F
    López-Vélez, R
    Pulido, F
    Salas, A
    Torre-Cisneros, J
    Torres, E
    Medrano, FJ
    Sanz, J
    Picó, G
    Gómez-Rodrigo, J
    Pasquau, J
    Alvar, J
    AIDS, 1999, 13 (09) : 1063 - 1069
  • [32] Formulation and characterisation of a self-nanoemulsifying drug delivery system of amphotericin B for the treatment of leishmaniasis
    Khan, Momin
    Nadhman, Akhtar
    Shah, Walayat
    Khan, Imran
    Yasinzai, Masoom
    IET NANOBIOTECHNOLOGY, 2019, 13 (05) : 477 - 483
  • [33] Advanced amphotericin-B gel formulation: An efficient approach to combat cutaneous leishmaniasis
    de Moura, Carla Veronica Rodarte
    Leite, Diego Botelho Campelo
    Muniz, Edvani Curti
    Mendes, Anderson Nogueira
    Filgueiras, Livia Alves
    de Abreu Junior, Adegildo Rolim
    Goncalves, Juan Carlos Ramos
    Marques, Karinne Kelly Gadelha
    Sobral, Marianna Vieira
    Araujo, Paulo Monteiro
    Rizzo, Marcia dos Santos
    Carvalho, Fernando Aecio de Amorim
    Alves, Michel Mualem de Moraes
    Carvalho, Andre Luis Menezes
    do Nascimento, Matheus Oliveira
    BIOMATERIALS ADVANCES, 2025, 172
  • [34] Amphotericin B liposomal formulation: applicable preparation methods, challenges, and tips
    Seify, Rogayeh
    Zahednezhad, Fahimeh
    Zakeri-Milani, Parvin
    Valizadeh, Hadi
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2023, 49 (05) : 367 - 376
  • [35] TREATMENT OF CRYPTOCOCCOSIS WITH LIPOSOMAL AMPHOTERICIN-B (AMBISOME) IN 23 PATIENTS WITH AIDS
    COKER, RJ
    VIVIANI, M
    GAZZARD, BG
    DUPONT, B
    POHLE, HD
    MURPHY, SM
    ATOUGUIA, J
    CHAMPALIMAUD, JL
    HARRIS, JRW
    AIDS, 1993, 7 (06) : 829 - 835
  • [36] Use of liposomal amphotericin B in the treatment of disseminated coccidioidomycosis
    Antony, S
    Dominguez, DC
    Sotelo, E
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2003, 95 (10) : 982 - 985
  • [37] New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment
    Chavez-Fumagalli, Miguel Angel
    Ribeiro, Tatiana Gomes
    Castilho, Rachel Oliveira
    Antunes Fernandes, Simone Odilia
    Cardoso, Valbert Nascimento
    Perilo Coelho, Cecilia Steinberg
    Costa Mendonca, Debora Vasconcelos
    Soto, Manuel
    Pereira Tavares, Carlos Alberto
    Gomes Faraco, Andre Augusto
    Coelho, Eduardo Antonio Ferraz
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2015, 48 (03) : 235 - 242
  • [38] Microneedle-Based Delivery of Amphotericin B for Treatment of Cutaneous Leishmaniasis
    Alexander K. Nguyen
    Kai-Hung Yang
    Kelsey Bryant
    Junan Li
    April C. Joice
    Karl A. Werbovetz
    Roger J. Narayan
    Biomedical Microdevices, 2019, 21
  • [39] Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
    Kafetzis, DA
    Velissariou, IM
    Stabouli, S
    Mavrikou, M
    Delis, D
    Liapi, G
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 25 (01) : 26 - 30
  • [40] Microneedle-Based Delivery of Amphotericin B for Treatment of Cutaneous Leishmaniasis
    Nguyen, Alexander K.
    Yang, Kai-Hung
    Bryant, Kelsey
    Li, Junan
    Joice, April C.
    Werbovetz, Karl A.
    Narayan, Roger J.
    BIOMEDICAL MICRODEVICES, 2019, 21 (01)